Anika Therapeutics
Bedford
About Anika Therapeutics
Anika Therapeutics, Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. We partner with physicians to understand what they need most in order to treat their patients and we develop minimally invasive products that restore active living for people around the world. We are committed to leading in high opportunity spaces within orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair and bone preserving joint technologies. Anika. Restore Active Living.™
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 251 – 500
- Estimated revenue: $100K – $500K
- Funding stage: IPO
- Last round: Post-IPO Equity (Mar 2024)
- Ticker: nasdaq:ANIK
- Website: anikatherapeutics.com
- Phone: 781-457-9000
Industries & Categories
Biotechnology, Health Care, Manufacturing, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/anika-therapeutics-203904 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.